Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 11329056)

Published in Nat Med on May 01, 2001

Authors

S Maier1, C Tertilt, N Chambron, K Gerauer, N Hüser, C D Heidecke, K Pfeffer

Author Affiliations

1: Department of Surgery, Immunology and Hygiene, Technische Universität München, Munich, Germany.

Articles citing this

In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med (2003) 2.59

Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest (2007) 1.75

Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells. Am J Respir Crit Care Med (2013) 1.50

Compartmentalized production of CCL17 in vivo: strong inducibility in peripheral dendritic cells contrasts selective absence from the spleen. J Exp Med (2003) 1.41

Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection. J Clin Invest (2001) 1.31

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest (2014) 1.16

Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. Transplantation (2008) 1.15

IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am J Transplant (2005) 1.14

The innate immune system in allograft rejection and tolerance. J Immunol (2007) 1.13

Germinal center alloantibody responses are mediated exclusively by indirect-pathway CD4 T follicular helper cells. J Immunol (2012) 1.08

NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol (2010) 1.04

Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant (2009) 1.02

CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors. J Immunol (2010) 1.01

Central memory CD8+ T lymphocytes mediate lung allograft acceptance. J Clin Invest (2014) 0.99

Immunosuppression for lung transplantation. Front Biosci (Landmark Ed) (2009) 0.95

Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection. J Exp Med (2005) 0.93

Innate immunity and cardiac allograft rejection. Kidney Int Suppl (2010) 0.90

Impaired immune responses and prolonged allograft survival in Sly1 mutant mice. Mol Cell Biol (2005) 0.90

Mechanisms of chronic rejection in cardiothoracic transplantation. Front Biosci (2008) 0.89

Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev (2014) 0.86

NK cells: elusive participants in transplantation immunity and tolerance. Curr Opin Immunol (2010) 0.86

Evolving paradigms that determine the fate of an allograft. Am J Transplant (2010) 0.86

Hunting for clinical translation with innate-like immune cells and their receptors. Leukemia (2013) 0.86

NKp30 is a functional activation receptor on a subset of rat natural killer cells. Eur J Immunol (2006) 0.86

Innate immunity and resistance to tolerogenesis in allotransplantation. Front Immunol (2012) 0.85

Peripheral natural killer cell and allo-stimulated T-cell function in kidney transplant recipients associate with cancer risk and immunosuppression-related complications. Kidney Int (2015) 0.85

Natural killer cells in rejection and tolerance of solid organ allografts. Curr Opin Organ Transplant (2011) 0.84

The innate immune system in transplantation. Semin Immunol (2011) 0.84

A role for SHIP in stem cell biology and transplantation. Curr Stem Cell Res Ther (2008) 0.83

Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism. Immunol Rev (2008) 0.83

Murine Models of Transplantation Tolerance through Mixed Chimerism: Advances and Roadblocks. Clin Exp Immunol (2017) 0.83

The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance. Transplantation (2010) 0.82

Impact of interleukin-12, oxidative burst, and iNOS on the survival of murine fecal peritonitis. Int J Colorectal Dis (2005) 0.82

KIR and HLA-C interactions promote differential dendritic cell maturation and is a major determinant of graft failure following kidney transplantation. PLoS One (2011) 0.81

NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. Transplantation (2012) 0.81

CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival. PLoS One (2013) 0.81

Immunology in the Clinic Review Series; focus on host responses: invariant natural killer T cell activation following transplantation. Clin Exp Immunol (2012) 0.80

HLA class I antibody-mediated endothelial and smooth muscle cell activation. Curr Opin Organ Transplant (2012) 0.80

Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79

CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses. Clin Exp Immunol (2006) 0.79

NKG2D and its ligands: active factors in the outcome of solid organ transplantation? Kidney Int Suppl (2011) (2011) 0.79

Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology. Transpl Immunol (2011) 0.78

An overview on non-T cell pathways in transplant rejection and tolerance. Curr Opin Organ Transplant (2010) 0.78

Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies. Front Immunol (2016) 0.77

Tolerance-inducing strategies in transplantation surgery-current status and perspectives. Langenbecks Arch Surg (2003) 0.77

NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization. J Immunol (2009) 0.77

Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep (2016) 0.77

T Cells Going Innate. Trends Immunol (2016) 0.77

Brain-derived neurotrophic factor modulates immune reaction in mice with peripheral nerve xenotransplantation. Neuropsychiatr Dis Treat (2016) 0.76

Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction. Immunology (2006) 0.76

The Impact of HLA Class I-Specific Killer Cell Immunoglobulin-Like Receptors on Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity and Organ Allograft Rejection. Front Immunol (2016) 0.75

Role of NK, NKT cells and macrophages in liver transplantation. World J Gastroenterol (2016) 0.75

Macrophages as Effectors of Acute and Chronic Allograft Injury. Curr Transplant Rep (2016) 0.75

Deletion of the Activating NK Cell Receptor NKG2D Accelerates Rejection of Cardiac Allografts. Am J Transplant (2017) 0.75

Articles by these authors

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity (1995) 10.65

Differential T cell costimulatory requirements in CD28-deficient mice. Science (1993) 6.93

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell (1998) 4.77

The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity (1998) 4.56

Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell (1993) 4.46

Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet (2000) 3.92

Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell (1993) 3.07

Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A (1997) 2.37

Two families of GTPases dominate the complex cellular response to IFN-gamma. J Immunol (1998) 2.27

Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity (2000) 2.17

Mature follicular dendritic cell networks depend on expression of lymphotoxin beta receptor by radioresistant stromal cells and of lymphotoxin beta and tumor necrosis factor by B cells. J Exp Med (1999) 2.11

A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol (1991) 2.06

Defective Peyer's patch organogenesis in mice lacking the 55-kD receptor for tumor necrosis factor. J Exp Med (1996) 2.02

Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol (1996) 1.73

Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64

Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60

Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease. Circulation (1997) 1.54

Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun (1999) 1.52

The role of tumor necrosis factor in the development of multiple organ failure in a murine model. Crit Care Med (2000) 1.51

Listeriosis in p47(phox-/-) and TRp55-/- mice: protection despite absence of ROI and susceptibility despite presence of RNI. Immunity (1997) 1.50

Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol (1996) 1.45

Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun (1997) 1.44

Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol (2001) 1.41

Plasmodium falciparum merozoites primarily stimulate the V gamma 9 subset of human gamma/delta T cells. Eur J Immunol (1991) 1.34

Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/- mice is dependent on T cells and IL-12. J Immunol (2000) 1.30

Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol (2000) 1.26

Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur J Immunol (1996) 1.25

PUMA-G, an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily. Eur J Immunol (2001) 1.15

Role of interleukin-18 (IL-18) during lethal shock: decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice. Infect Immun (2000) 1.09

Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol (1998) 1.07

Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues. Cytokine (2000) 1.07

Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease. Res Exp Med (Berl) (1982) 1.07

Identification and functional importance of IL-1 receptors on rat parietal cells. Am J Physiol (1998) 1.07

Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice. Eur J Immunol (1998) 1.07

Endoscopic transanal vacuum-assisted rectal drainage (ETVARD): an optimized therapy for major leaks from extraperitoneal rectal anastomoses. Endoscopy (2008) 1.06

A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol (1999) 1.05

V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. J Immunol (1992) 1.04

TNF receptor p55 controls early acute graft-versus-host disease. J Immunol (1997) 1.04

Mechanisms of acute inflammatory lung injury induced by abdominal sepsis. Int Immunol (1999) 1.04

Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J (1999) 1.04

Critical role of Kupffer cell-derived IL-10 for host defense in septic peritonitis. J Immunol (2001) 1.02

Phosphorylation of Atg5 by the Gadd45β-MEKK4-p38 pathway inhibits autophagy. Cell Death Differ (2012) 1.01

In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells. J Immunol (1985) 1.01

Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am J Pathol (2000) 1.01

TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes. J Immunol (1999) 1.01

The battle of two genomes: genetics of bacterial host/pathogen interactions in mice. Mamm Genome (2001) 1.00

Mechanisms of rejection and prolongation of vascularized organ allografts. Immunol Rev (1984) 0.99

[Infection prevention check-in and infection prevention check-out to prevent nosocomial infections]. Zentralbl Chir (2009) 0.98

CD28 signals through acidic sphingomyelinase. J Exp Med (1995) 0.98

Sepsis after major visceral surgery is associated with sustained and interferon-gamma-resistant defects of monocyte cytokine production. Surgery (2000) 0.98

Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2(-/-) hematopoietic progenitors. Blood (2001) 0.98

Choosing a safe place to cross the road: the relationship between attention and identification of safe and dangerous road-crossing sites. Child Care Health Dev (2003) 0.97

A syngeneic orthotopic murine model of pancreatic adenocarcinoma in the C57/BL6 mouse using the Panc02 and 6606PDA cell lines. Eur Surg Res (2011) 0.96

Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development. J Immunol (2001) 0.94

Opportunist mycobacteria express ligands that stimulate production of human V gamma 9V delta 2 T lymphocytes. Infect Immun (1992) 0.94

Interactions between T lymphocyte subsets supported by interleukin 2-rich lymphokines produce acute rejection of vascularized cardiac allografts in T cell deprived rats. J Immunol (1984) 0.93

Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock (2000) 0.91

Adoptive transfer of human peripheral blood lymphocytes (PBL) in scid mice. Curr Top Microbiol Immunol (1989) 0.90

LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins. J Pharm Biomed Anal (2013) 0.89

A rapid method for semiquantitative analysis of the human V beta-repertoire using TaqManR PCR. J Immunol Methods (1997) 0.88

Impact of experimental peritonitis on bone marrow cell function. Surgery (1999) 0.88

Microglial major histocompatibility complex glycoprotein-1 in the axotomized facial motor nucleus: regulation and role of tumor necrosis factor receptors 1 and 2. J Comp Neurol (2004) 0.87

Hepatocyte nitric oxide biosynthesis inhibits glucose output and competes with urea synthesis for L-arginine. Am J Physiol (1995) 0.86

Fulminate intracardiac thrombosis associated with Budd-Chiari-syndrome and inferior vena cava thrombosis. Vasa (2002) 0.86

Phenotype, activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts. Transplantation (1985) 0.85

MRI and determination of T1 and T2 of solid polymers using a 1.5 T whole-body imager. Magn Reson Imaging (1993) 0.85

The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology (1999) 0.83

Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer. Pancreatology (2013) 0.83

T-lymphocyte development and function in gene-targeted mutant mice. Immunol Rev (1995) 0.83

Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium. Res Exp Med (Berl) (1981) 0.82

Cyclosporine therapy of rat heart allograft recipients and release of interleukins (IL 1, IL 2, IL 3): a role for IL 3 in graft tolerance? J Immunol (1984) 0.82

Phenotypic and functional characterization of human TCR gamma delta+ intestinal intraepithelial lymphocytes. Curr Top Microbiol Immunol (1991) 0.82

Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts. Transplantation (1985) 0.82

Lung injury and oxidoreductases. Environ Health Perspect (1998) 0.82

Transcriptional regulation of human xanthine dehydrogenase/xanthine oxidase. Biochem Soc Trans (1997) 0.82

[What is the appropriate time-interval for changing gloves during surgical procedures]. Zentralbl Chir (2010) 0.82

Restoration of allograft responsiveness in B rats. IV. The divergent migratory behavior of lymphocyte populations mediating cardiac allograft rejection. Cell Immunol (1984) 0.81

Major histocompatibility complex (MHC2+) perivascular macrophages in the axotomized facial motor nucleus are regulated by receptors for interferon-gamma (IFNgamma) and tumor necrosis factor (TNF). Neuroscience (2005) 0.81

Intact lysosome transport and phagosome function despite kinectin deficiency. Mol Cell Biol (2001) 0.81

Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes. Mutat Res (1997) 0.80

Tumor necrosis factors in 1998. Cytokine Growth Factor Rev (1999) 0.80

Immunity to mycobacteria: possible role of alpha/beta and gamma/delta T lymphocytes. APMIS (1990) 0.79

Restoration of allograft responsiveness in B rats. II. Requirements for lymphoid populations and lymphokine. Transplantation (1983) 0.79

Antimicrobial effects of murine mesenchymal stromal cells directed against Toxoplasma gondii and Neospora caninum: role of immunity-related GTPases (IRGs) and guanylate-binding proteins (GBPs). Med Microbiol Immunol (2012) 0.79

Anti-platelet factor 4/heparin antibodies in patients with impaired graft function after liver transplantation. J Thromb Haemost (2014) 0.79

Modeling of esophageal bolus flow by functional data analysis of scintigrams. Dis Esophagus (2004) 0.78

The resistance against Listeria monocytogenes and the formation of germinal centers depend on a functional death domain of the 55 kDa tumor necrosis factor receptor. Eur J Immunol (1999) 0.78

Laser-supported diaphanoscopy: an innovative technique for locating gastric stromal tumors in gastroscopic-laparoscopic rendezvous: a case series. Endoscopy (2009) 0.78

Bronchogenic cyst of the esophagus with high tumor marker levels--a case report and review of the literature. Dis Esophagus (1998) 0.78

Laser-supported diaphanoscopy: a new technique in laparoscopic-endoscopic rendezvous procedures allowing better and more tissue-sparing tumor resection than wedge resection. Surg Endosc (2010) 0.78

Effects of the H2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease. J Cardiovasc Pharmacol (1983) 0.77

Interventional radiology in the treatment of blunt liver trauma: case report with review of literature. Bildgebung (1996) 0.77

In vivo imaging of bile accumulation and biliary infarction after common bile duct ligation in rats. Eur Surg Res (2011) 0.77

Apparent superiority of H2-receptor stimulation and simultaneous beta-blockade over conventional treatment with beta-sympathomimetic drugs in post-acute myocardial infarction: cardiac effects of impromidine--a new specific H2-receptor agonist-in the surviving catecholamine-insensitive myocardium. Agents Actions (1984) 0.77

[Characteristics of necrosis after laser-induced thermotherapy in contrast-enhanced MRI and implications for treatment success]. Rofo (2008) 0.77